跳到正文
原文
Nature Immunology· Congyi Niu·· 7 天前AI 评分35

CLEC9A 和 DEC205 CAR-DCs 用于肿瘤免疫治疗

Rewiring dendritic cell function with CLEC9A and DEC205 CARs

AI 导读

研究者通过改造树突状细胞(DCs),使用 CLEC9A 和 DEC205 的胞内结构域构建 CAR-DCs,以交叉提呈肿瘤抗原,诱导 CD8+ T 细胞杀伤肿瘤,实验结果显示在人源化小鼠模型中有效。

正文

Nature Immunology, Published online: 13 November 2026; doi:10.1038/s41590-026-02711-3

Chimeric antigen receptor dendritic cells (CAR-DCs) are sometimes engineered in the manner of T cells to enhance specific DC functions. Here, the authors engineer CAR-DCs with the intracellular domains of the endocytic receptors CLEC9A and DEC205 to make an immunotherapeutic that cross-presents tumor antigens to induce CD8+ T cell killing of tumors in humanized mice.

来源:Nature Immunology · nature.com